Cody Carter
Interventional Cardiology · Grand Rapids, MINPI 1174012132
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.4%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 32.8% of the total. 2025 is the largest year on record at $7,833, more than ten times the $115 reported in 2019.
Across 114 payments — averaging $107.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$2K
- Abbott$2K
- AstraZeneca$739
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$481
- Actelion Pharmaceuticals US, Inc.$472
- plus $2K from 18 others
What the payments were for
- Grants$4,00033%
- Travel & lodging$1,72314%
- Food & beverage$6,42452%
- Education$1141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $4,020 |
| Boston Scientific | 31 | $2,352 |
| Abbott | 16 | $2,325 |
| AstraZeneca | 11 | $739 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $481 |
| Actelion Pharmaceuticals US, Inc. | 5 | $472 |
| Johnson & Johnson | 9 | $308 |
| Abiomed | 4 | $306 |
| ZOLL Circulation Inc | 3 | $195 |
| Inari Medical, Inc. | 1 | $154 |
| Esperion Therapeutics, Inc. | 1 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Bayer | 1 | $122 |
| Boehringer Ingelheim | 1 | $118 |
| Amgen | 2 | $114 |
| Portola Pharmaceuticals, LLC | 1 | $114 |
| Teleflex LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Cardiva Medical, Inc. | 1 | $27 |
| Heartflow, Inc. | 1 | $21 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
| Cordis US CORP. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Biosense Webster, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$1,727
- GENERAL VASCULAR ACCESS$706
- OPSUMIT$453
- WATCHMAN FLX$445
- UPTRAVI$338
- GENERAL - THERAPIES$280
- FARXIGA$226
- WATCHMAN Access System$220
- FlowTriever$154
- ClotTriever$154
- TherOx DS2 Console$150
- Catheter$150
- Downstream Cartridge$150
- General - Balloon Catheters$148
- CARDIOMEMS$135
- Impella$128
- NEXLIZET$126
- NEXLETOL$126
- NURTEC ODT$125
- Adempas$122
How this compares
$12,261 in reported general payments places this provider in the 65th percentile of 187 interventional cardiology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 32 | $261 |
| ClopidogrelClopidogrel Bisulfate | 43 | $218 |
| Metoprolol Succinate | 36 | $175 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Grand Rapids
- Duane BerkompasGrand Rapids$159K
- David WohnsGrand Rapids$129K
- William MerhiGrand Rapids$114K
- Timothy JosephGrand Rapids$17K
- Devraj SukulGrand Rapids$13K
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.